| PubMed |
Abstract |
RScore(About this table) |
| 12234126 |
Hamplova-Peichlova J, Krusek J, Paclt I, Slavicek J, Lisa V, Vyskocil F: Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture. Physiol Res. 2002;51(3):317-21.
|
2(0,0,0,2) |
Details |
| 16002434 |
Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH: Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95. Epub 2005 Jul 7.
These experiments also revealed 16 VDREs in 11 of 12 genes induced more than 10-fold in our previous microarray study, five elements in the human gene encoding the epithelial calcium channel TRPV6, as well as novel 1,25 (OH2) D3 target genes implicated in regulation of cell cycle progression. |
1(0,0,0,1) |
Details |
| 16232003 |
Landsman PB, Yu W, Liu X, Teutsch SM, Berger ML: Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care. 2005 Oct;11(10):621-8.
Study subjects needed 24 months of continuous coverage and a prescription filled < OR = 3 months before the benefit change for a nonsteroidal anti-inflammatory agent (NSAID), a cyclooxygenase (COX-2) inhibitor, a selective serotonin reuptake inhibitor (SSRI), a tricyclic antidepressant (TCA), an angiotensin-converting enzyme (ACE) inhibitor, a calcium-channel blocker (CCB), an angiotensin-receptor blocker (ARB), a statin, or a triptan. |
1(0,0,0,1) |
Details |